Survival and Toxicities after 90Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry
Authors:
- Erica C. EmmonsEEErica C. Emmons
- Steven BishaySBSteven Bishay
- Liping DuLDLiping Du
- Henry KrebsHKHenry Krebs
- Ripal T. GandhiRGRipal T. Gandhi
- Zachary S. CollinsZCZachary S. Collins
- Ryan O’hAraRORyan O’hAra
- Nabeel M. AkhterNANabeel M. Akhter
- Eric A. WangEWEric A. Wang
- Christopher GrilliCGChristopher Grilli
- Jayson S. BrowerJBJayson S. Brower
- Shannon R. PeckSPShannon R. Peck
- 1 October 2022
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 305 (1) , 228-236
Abstract
Transarterial radioembolization with yttrium 90 microspheres resulted in 15.0-month overall survival in 498 participants with metastatic colorectal cancer: 17.4 months when integrated with second-l... Background Patients with unresectable, chemorefractory hepatic metastases from colorectal cancer have considerable mortality. The role of transarterial radioembolization (TARE) with yttrium 90 (90Y...Keywords
Funding Information
- Sirtex Medical, Woburn, Mass
This publication has 16 references indexed in Scilit:
- Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastasesJournal of Gastrointestinal Oncology, 2017
- Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal CancerClinical Colorectal Cancer, 2016
- 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter StudyJournal of Nuclear Medicine, 2015
- Randomized Trial of TAS-102 for Refractory Metastatic Colorectal CancerNew England Journal of Medicine, 2015
- Is Yttrium-90 Radioembolization a Viable Treatment Option for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases? A Large Single-Center Experience of 302 PatientsAnnals of Surgical Oncology, 2014
- Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trialThe Lancet, 2013
- Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal MetastasesCardioVascular and Interventional Radiology, 2011
- Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard ChemotherapyJournal of Clinical Oncology, 2010
- Management of Hepatic Metastases from Colorectal CancerClinics in Colon and Rectal Surgery, 2005